Arrowhead Pharmaceuticals, Inc. (ARWR)
73.34
-0.52
(-0.70%)
USD |
NASDAQ |
Jun 09, 16:00
73.34
0.00 (0.00%)
After-Hours: 16:59
Arrowhead Pharmaceuticals SG&A Expense (Quarterly) : 41.74M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 108.95M |
| Revolution Medicines, Inc. | 101.25M |
| Kymera Therapeutics, Inc. | 20.36M |
| ImmunityBio, Inc. | 45.77M |
| Vera Therapeutics, Inc. | 39.12M |